speb/financial-data huggingface dataset:
CMDB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 682906000.00
CMDB income_statement (quarterly, 2025-09-30) — Total Expenses: 227176000.00
CMDB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 383656000.00
CMDB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 752212000.00
CMDB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 153840000.00
CMDB income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -9442000.00
CMDB income_statement (quarterly, 2025-09-30) — Total Unusual Items: 13351000.00
CMDB income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 13351000.00
CMDB balance_sheet (quarterly, 2025-09-30) — Working Capital: 84534000.00
CMDB income_statement (annual, 2025-12-31) — +Operating Expense: 87904000.00
CMDB income_statement (quarterly, 2025-12-31) — +Operating Expense: 29277000.00
CMDB income_statement (annual, 2025-12-31) — +Total Revenue: 597223000.00
CMDB income_statement (quarterly, 2025-12-31) — +Total Revenue: 218483000.00
CMDB balance_sheet (annual, 2025-12-31) — Accounts Payable: 26028000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 26028000.00
CMDB balance_sheet (annual, 2025-12-31) — Accounts Receivable: 22597000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 22597000.00
CMDB balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -27054000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -27054000.00
CMDB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 702992000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 702992000.00
CMDB income_statement (annual, 2025-12-31) — Amortization: 5206000.00
CMDB income_statement (quarterly, 2025-12-31) — Amortization: 1649000.00
CMDB income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 5206000.00
CMDB income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 1649000.00
CMDB income_statement (annual, 2025-12-31) — Basic Average Shares: 16374555.00
CMDB income_statement (quarterly, 2025-12-31) — Basic Average Shares: 24148902.00
CMDB income_statement (annual, 2025-12-31) — Basic EPS: -2.28
CMDB income_statement (quarterly, 2025-12-31) — Basic EPS: -0.75
CMDB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2104000.00
CMDB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 184457000.00
CMDB cash_flow (annual, 2025-12-31) — Capital Expenditure: -31692000.00
CMDB cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -451000.00
CMDB balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 39155000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 39155000.00
CMDB balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
CMDB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 211845000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 211845000.00
CMDB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 211845000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 211845000.00
CMDB cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
CMDB cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
CMDB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 63260000.00
CMDB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3919000.00
CMDB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 74543000.00
CMDB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 8555000.00
CMDB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 75588000.00
CMDB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 26402000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Account Payable: -2175000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2169000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -2235000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -3226000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Inventory: 25690000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Inventory: 18342000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 5876000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 10827000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -8090000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -8769000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Payable: -5838000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Payable: -8442000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -8073000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -11668000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 17838000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 4009000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Receivables: 36886000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Receivables: 20816000.00
CMDB cash_flow (annual, 2025-12-31) — Change In Working Capital: 70127000.00
CMDB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 33557000.00
CMDB cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 32331000.00
CMDB cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 19983000.00
CMDB cash_flow (annual, 2025-12-31) — Changes In Cash: 213391000.00
CMDB cash_flow (quarterly, 2025-12-31) — Changes In Cash: 31038000.00
CMDB balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
CMDB balance_sheet (annual, 2025-12-31) — Common Stock Equity: 665648000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 665648000.00
CMDB income_statement (annual, 2025-12-31) — Cost Of Revenue: 528167000.00
CMDB income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 191812000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 9732000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 9732000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Assets: 293649000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Assets: 293649000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 39155000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 39155000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Debt: 14995000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Debt: 14995000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 54150000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 54150000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 11911000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 11911000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 11911000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 11911000.00
CMDB balance_sheet (annual, 2025-12-31) — Current Liabilities: 123176000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 123176000.00
CMDB cash_flow (annual, 2025-12-31) — Depreciation: 28410000.00
CMDB cash_flow (quarterly, 2025-12-31) — Depreciation: 9194000.00
CMDB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 28410000.00
CMDB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 9194000.00
CMDB income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 5206000.00
CMDB income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1649000.00
CMDB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 28410000.00
CMDB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 9194000.00
CMDB income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 5206000.00
CMDB income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1649000.00
CMDB income_statement (annual, 2025-12-31) — Diluted Average Shares: 16374555.00
CMDB income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 24148902.00
CMDB income_statement (annual, 2025-12-31) — Diluted EPS: -2.28
CMDB income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.75
CMDB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -18191000.00
CMDB balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 4444000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 4444000.00
CMDB balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Non Current: 1050000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Non Current: 1050000.00
CMDB balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 5145000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 5145000.00
CMDB income_statement (annual, 2025-12-31) — EBIT: -28327000.00
CMDB income_statement (quarterly, 2025-12-31) — EBIT: -15001000.00
CMDB income_statement (annual, 2025-12-31) — EBITDA: 83000.00
CMDB income_statement (quarterly, 2025-12-31) — EBITDA: -5807000.00
CMDB cash_flow (annual, 2025-12-31) — End Cash Position: 215495000.00
CMDB cash_flow (quarterly, 2025-12-31) — End Cash Position: 215495000.00
CMDB cash_flow (annual, 2025-12-31) — Financing Cash Flow: 63260000.00
CMDB cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3919000.00
CMDB cash_flow (annual, 2025-12-31) — Free Cash Flow: 43896000.00
CMDB cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 25951000.00
CMDB cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -5265000.00
CMDB cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -933000.00
CMDB cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 11456000.00
CMDB cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -1000.00
CMDB income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -11456000.00
CMDB income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 1000.00
CMDB income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 12628000.00
CMDB income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -387000.00
CMDB income_statement (annual, 2025-12-31) — General And Administrative Expense: 10651000.00
CMDB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3989000.00
CMDB balance_sheet (annual, 2025-12-31) — Gross PPE: 634268000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Gross PPE: 634268000.00
CMDB income_statement (annual, 2025-12-31) — Gross Profit: 69056000.00
CMDB income_statement (quarterly, 2025-12-31) — Gross Profit: 26671000.00
CMDB balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 268000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 268000.00
CMDB income_statement (annual, 2025-12-31) — Interest Expense: 9025000.00
CMDB income_statement (quarterly, 2025-12-31) — Interest Expense: 3190000.00
CMDB income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 9025000.00
CMDB income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3190000.00
CMDB income_statement (annual, 2025-12-31) — Interest Income: 3136000.00
CMDB income_statement (quarterly, 2025-12-31) — Interest Income: 1339000.00
CMDB income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3136000.00
CMDB income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1339000.00
CMDB cash_flow (annual, 2025-12-31) — Interest Paid Cff: -103000.00
CMDB cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: 0.00
CMDB cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 8608000.00
CMDB cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2347000.00
CMDB balance_sheet (annual, 2025-12-31) — Inventory: 14217000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Inventory: 14217000.00
CMDB balance_sheet (annual, 2025-12-31) — Invested Capital: 821242000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Invested Capital: 821242000.00
CMDB cash_flow (annual, 2025-12-31) — Investing Cash Flow: 74543000.00
CMDB cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 8555000.00
CMDB cash_flow (annual, 2025-12-31) — Issuance Of Debt: 15300000.00
CMDB cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CMDB balance_sheet (annual, 2025-12-31) — Long Term Debt: 140599000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 140599000.00
CMDB balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 140599000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 140599000.00
CMDB cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 15300000.00
CMDB cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CMDB cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -182502000.00
CMDB cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3919000.00
CMDB cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 22805000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CMDB income_statement (annual, 2025-12-31) — Net Income: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Income: -18191000.00
CMDB income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -18191000.00
CMDB income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -18191000.00
CMDB income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -18191000.00
CMDB income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -18191000.00
CMDB cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -37352000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -18191000.00
CMDB income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -18191000.00
CMDB income_statement (annual, 2025-12-31) — Net Interest Income: -6560000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Interest Income: -1452000.00
CMDB cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -167202000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3919000.00
CMDB cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -167202000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3919000.00
CMDB income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -6560000.00
CMDB income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1452000.00
CMDB cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 230565000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
CMDB cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 427000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 4000.00
CMDB balance_sheet (annual, 2025-12-31) — Net PPE: 607214000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Net PPE: 607214000.00
CMDB cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 51311000.00
CMDB cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 8551000.00
CMDB cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CMDB balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 665648000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 665648000.00
CMDB balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 6553000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 6553000.00
CMDB balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 18357000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 18357000.00
CMDB income_statement (annual, 2025-12-31) — Normalized EBITDA: -1089000.00
CMDB income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -5421000.00
CMDB income_statement (annual, 2025-12-31) — Normalized Income: -38524000.00
CMDB income_statement (quarterly, 2025-12-31) — Normalized Income: -17805000.00
CMDB cash_flow (annual, 2025-12-31) — Operating Cash Flow: 75588000.00
CMDB cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 26402000.00
CMDB cash_flow (annual, 2025-12-31) — Operating Gains Losses: 6191000.00
CMDB cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -934000.00
CMDB income_statement (annual, 2025-12-31) — Operating Income: -18848000.00
CMDB income_statement (quarterly, 2025-12-31) — Operating Income: -2606000.00
CMDB income_statement (annual, 2025-12-31) — Operating Revenue: 597223000.00
CMDB income_statement (quarterly, 2025-12-31) — Operating Revenue: 218483000.00
CMDB balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 24180472.00
CMDB balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 24180472.00
CMDB balance_sheet (annual, 2025-12-31) — Other Current Assets: 24668000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 24668000.00
CMDB balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 14995000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 14995000.00
CMDB balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 16210000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 16210000.00
CMDB income_statement (annual, 2025-12-31) — Other Gand A: 10651000.00
CMDB income_statement (quarterly, 2025-12-31) — Other Gand A: 3989000.00
CMDB income_statement (annual, 2025-12-31) — Other Income Expense: -11944000.00
CMDB income_statement (quarterly, 2025-12-31) — Other Income Expense: -14133000.00
CMDB cash_flow (annual, 2025-12-31) — Other Non Cash Items: 6087000.00
CMDB cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1843000.00
CMDB balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 3650000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 3650000.00
CMDB income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -13116000.00
CMDB income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -13747000.00
CMDB income_statement (annual, 2025-12-31) — Other Operating Expenses: 77253000.00
CMDB income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 25288000.00
CMDB balance_sheet (annual, 2025-12-31) — Other Properties: 41667000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Other Properties: 41667000.00
CMDB balance_sheet (annual, 2025-12-31) — Other Receivables: 4785000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Other Receivables: 4785000.00
CMDB balance_sheet (annual, 2025-12-31) — Payables: 31173000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Payables: 31173000.00
CMDB balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 40905000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 40905000.00
CMDB income_statement (annual, 2025-12-31) — Pretax Income: -37352000.00
CMDB income_statement (quarterly, 2025-12-31) — Pretax Income: -18191000.00
CMDB cash_flow (annual, 2025-12-31) — Purchase Of PPE: -31692000.00
CMDB cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -451000.00
CMDB balance_sheet (annual, 2025-12-31) — Receivables: 31826000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Receivables: 31826000.00
CMDB income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 528167000.00
CMDB income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 191812000.00
CMDB income_statement (annual, 2025-12-31) — Reconciled Depreciation: 28410000.00
CMDB income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 9194000.00
CMDB income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 325510000.00
CMDB income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 133366000.00
CMDB cash_flow (annual, 2025-12-31) — Repayment Of Debt: -182502000.00
CMDB cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3919000.00
CMDB balance_sheet (annual, 2025-12-31) — Restricted Cash: 10825000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 10825000.00
CMDB balance_sheet (annual, 2025-12-31) — Retained Earnings: -37346000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -37346000.00
CMDB cash_flow (annual, 2025-12-31) — Sale Of Business: 22805000.00
CMDB cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CMDB cash_flow (annual, 2025-12-31) — Sale Of PPE: 83003000.00
CMDB cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 9002000.00
CMDB income_statement (annual, 2025-12-31) — Selling General And Administration: 10651000.00
CMDB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3989000.00
CMDB balance_sheet (annual, 2025-12-31) — Share Issued: 24362000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Share Issued: 24362000.00
CMDB cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
CMDB income_statement (annual, 2025-12-31) — Special Income Charges: -11456000.00
CMDB income_statement (quarterly, 2025-12-31) — Special Income Charges: 1000.00
CMDB cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2125000.00
CMDB cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 933000.00
CMDB balance_sheet (annual, 2025-12-31) — Stockholders Equity: 665648000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 665648000.00
CMDB balance_sheet (annual, 2025-12-31) — Tangible Book Value: 665648000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 665648000.00
CMDB income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CMDB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CMDB income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CMDB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CMDB balance_sheet (annual, 2025-12-31) — Total Assets: 929423000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Assets: 929423000.00
CMDB balance_sheet (annual, 2025-12-31) — Total Capitalization: 806247000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 806247000.00
CMDB balance_sheet (annual, 2025-12-31) — Total Debt: 194749000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Debt: 194749000.00
CMDB balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 665648000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 665648000.00
CMDB income_statement (annual, 2025-12-31) — Total Expenses: 616071000.00
CMDB income_statement (quarterly, 2025-12-31) — Total Expenses: 221089000.00
CMDB balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 263775000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 263775000.00
CMDB balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 635774000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 635774000.00
CMDB balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 140599000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 140599000.00
CMDB income_statement (annual, 2025-12-31) — Total Other Finance Cost: 671000.00
CMDB income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -399000.00
CMDB income_statement (annual, 2025-12-31) — Total Unusual Items: 1172000.00
CMDB income_statement (quarterly, 2025-12-31) — Total Unusual Items: -386000.00
CMDB income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1172000.00
CMDB income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -386000.00
CMDB balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 181528.00
CMDB balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 181528.00
CMDB balance_sheet (annual, 2025-12-31) — Working Capital: 170473000.00
CMDB balance_sheet (quarterly, 2025-12-31) — Working Capital: 170473000.00
CMDB income_statement (quarterly, 2026-03-31) — +Operating Expense: 25340000.00
CMDB income_statement (quarterly, 2026-03-31) — +Total Revenue: 111508000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 26260000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 13607000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -33649000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 703928000.00
CMDB income_statement (quarterly, 2026-03-31) — Amortization: 1607000.00
CMDB income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 1607000.00
CMDB income_statement (quarterly, 2026-03-31) — Basic Average Shares: 24181817.00
CMDB income_statement (quarterly, 2026-03-31) — Basic EPS: 0.41
CMDB cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 215495000.00
CMDB cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5723000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 20648000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 255105000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 255105000.00
CMDB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -14559000.00
CMDB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 38586000.00
CMDB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 18933000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 232000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 1401000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Inventory: -352000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -1033000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -11340000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Payable: -98000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1303000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 10452000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Receivables: 9421000.00
CMDB cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 8451000.00
CMDB cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 9584000.00
CMDB cash_flow (quarterly, 2026-03-31) — Changes In Cash: 42960000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 676520000.00
CMDB income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 79998000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 11134000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Assets: 322264000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 20648000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Debt: 13962000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 34610000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 6725000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 6725000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 97983000.00
CMDB cash_flow (quarterly, 2026-03-31) — Depreciation: 8645000.00
CMDB cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 8645000.00
CMDB income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1607000.00
CMDB cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 8645000.00
CMDB income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1607000.00
CMDB income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 24181817.00
CMDB income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.41
CMDB income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 9936000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 4322000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Non Current: 975000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 4815000.00
CMDB income_statement (quarterly, 2026-03-31) — EBIT: 12297000.00
CMDB income_statement (quarterly, 2026-03-31) — EBITDA: 20942000.00
CMDB cash_flow (quarterly, 2026-03-31) — End Cash Position: 258455000.00
CMDB cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -14559000.00
CMDB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13210000.00
CMDB cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -3229000.00
CMDB cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -7741000.00
CMDB income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 7741000.00
CMDB income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 2267000.00
CMDB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 3210000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Gross PPE: 582244000.00
CMDB income_statement (quarterly, 2026-03-31) — Gross Profit: 31510000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 2673000.00
CMDB income_statement (quarterly, 2026-03-31) — Interest Expense: 2361000.00
CMDB income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2361000.00
CMDB income_statement (quarterly, 2026-03-31) — Interest Income: 1643000.00
CMDB income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1643000.00
CMDB cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 2107000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Inventory: 14569000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Invested Capital: 817883000.00
CMDB cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 38586000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 127401000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 127401000.00
CMDB cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -14559000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Income: 9936000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 9936000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 9936000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 9936000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 9936000.00
CMDB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 9936000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 9936000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Interest Income: -992000.00
CMDB cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -14559000.00
CMDB cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -14559000.00
CMDB income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -992000.00
CMDB cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 578000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Net PPE: 548595000.00
CMDB cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 38008000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 676520000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 6561000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 22160000.00
CMDB income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 10934000.00
CMDB income_statement (quarterly, 2026-03-31) — Normalized Income: 3931200.00
CMDB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 18933000.00
CMDB cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -10970000.00
CMDB income_statement (quarterly, 2026-03-31) — Operating Income: 6170000.00
CMDB income_statement (quarterly, 2026-03-31) — Operating Revenue: 111508000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 24240981.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 17273000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 13962000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 14439000.00
CMDB income_statement (quarterly, 2026-03-31) — Other Gand A: 3210000.00
CMDB income_statement (quarterly, 2026-03-31) — Other Income Expense: 4758000.00
CMDB cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1935000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3350000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1026000.00
CMDB income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -5250000.00
CMDB income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 22130000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Properties: 21216000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4567000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Payables: 31075000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 42209000.00
CMDB income_statement (quarterly, 2026-03-31) — Pretax Income: 9936000.00
CMDB cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -5723000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Receivables: 22496000.00
CMDB income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 79998000.00
CMDB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 8645000.00
CMDB income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 45976000.00
CMDB cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -14559000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 10148000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -27410000.00
CMDB cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 43731000.00
CMDB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3210000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Share Issued: 24422509.00
CMDB income_statement (quarterly, 2026-03-31) — Special Income Charges: 7741000.00
CMDB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 936000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 676520000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 676520000.00
CMDB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 4003200.00
CMDB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CMDB balance_sheet (quarterly, 2026-03-31) — Total Assets: 902930000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 803921000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Total Debt: 162011000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 676520000.00
CMDB income_statement (quarterly, 2026-03-31) — Total Expenses: 105338000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 226410000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 580666000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 128427000.00
CMDB income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 13837000.00
CMDB income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 274000.00
CMDB income_statement (quarterly, 2026-03-31) — Total Unusual Items: 10008000.00
CMDB income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 10008000.00
CMDB balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 181528.00
CMDB balance_sheet (quarterly, 2026-03-31) — Working Capital: 224281000.00
CME balance_sheet (annual, 2021-12-31) — Current Debt: 749400000.00
CME balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 749400000.00
CME balance_sheet (annual, 2021-12-31) — Current Notes Payable: 749400000.00
CME cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: -24400000.00
CME cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -400700000.00
CME cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -30400000.00
CME cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 965000000.00
CME balance_sheet (annual, 2021-12-31) — Land And Improvements: 0.00
CME balance_sheet (annual, 2021-12-31) — Minority Interest: 0.00
CME income_statement (annual, 2021-12-31) — Minority Interests: 500000.00
CME balance_sheet (annual, 2021-12-31) — Net Debt: 610200000.00
CME cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 965000000.00
CME cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
CME cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 965000000.00
CME cash_flow (annual, 2021-12-31) — Sale Of PPE: 39300000.00
CME cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
CME income_statement (annual, 2022-12-31) — +Operating Expense: 1250400000.00
CME income_statement (annual, 2022-12-31) — +Total Revenue: 5019400000.00
CME balance_sheet (annual, 2022-12-31) — Accounts Payable: 121400000.00
CME balance_sheet (annual, 2022-12-31) — Accounts Receivable: 483200000.00
CME balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1145200000.00
CME balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 22261600000.00
CME balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -8100000.00
CME income_statement (annual, 2022-12-31) — Amortization: 227700000.00
CME cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 227700000.00
CME cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 227700000.00
CME income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 227700000.00
CME income_statement (annual, 2022-12-31) — Basic Average Shares: 358713000.00
CME income_statement (annual, 2022-12-31) — Basic EPS: 7.41
CME cash_flow (annual, 2022-12-31) — Beginning Cash Position: 160789800000.00
CME balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 132200000.00
CME cash_flow (annual, 2022-12-31) — Capital Expenditure: -89700000.00
CME balance_sheet (annual, 2022-12-31) — Capital Stock: 3600000.00
CME balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 2720100000.00
CME balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 2816100000.00
CME cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2633500000.00
CME cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -25381700000.00
CME cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -489800000.00
CME cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 3056000000.00
CME cash_flow (annual, 2022-12-31) — Change In Account Payable: 72500000.00
CME cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -147800000.00
CME cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 10500000.00
CME cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 20700000.00
CME cash_flow (annual, 2022-12-31) — Change In Payable: -75300000.00
CME cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -75300000.00
CME cash_flow (annual, 2022-12-31) — Change In Receivables: -51100000.00
CME cash_flow (annual, 2022-12-31) — Change In Tax Payable: -147800000.00
CME cash_flow (annual, 2022-12-31) — Change In Working Capital: -95200000.00
CME cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -51100000.00
CME cash_flow (annual, 2022-12-31) — Changes In Cash: -22815500000.00
CME balance_sheet (annual, 2022-12-31) — Common Stock: 3600000.00
CME balance_sheet (annual, 2022-12-31) — Common Stock Equity: 26878700000.00
CME income_statement (annual, 2022-12-31) — Cost Of Revenue: 753100000.00
CME balance_sheet (annual, 2022-12-31) — Current Assets: 139078300000.00
CME balance_sheet (annual, 2022-12-31) — Current Debt: 16000000.00
CME balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 16000000.00
CME balance_sheet (annual, 2022-12-31) — Current Liabilities: 137687500000.00
CME balance_sheet (annual, 2022-12-31) — Current Notes Payable: 16000000.00
CME cash_flow (annual, 2022-12-31) — Deferred Income Tax: -23200000.00
CME cash_flow (annual, 2022-12-31) — Deferred Tax: -23200000.00
CME cash_flow (annual, 2022-12-31) — Depreciation: 134900000.00
CME cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 362600000.00
CME income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 362600000.00
CME cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 362600000.00
CME income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 362600000.00
CME income_statement (annual, 2022-12-31) — Depreciation Income Statement: 134900000.00
CME income_statement (annual, 2022-12-31) — Diluted Average Shares: 359181000.00
CME income_statement (annual, 2022-12-31) — Diluted EPS: 7.40
CME income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 2657200000.00
CME income_statement (annual, 2022-12-31) — EBIT: 3653000000.00
CME income_statement (annual, 2022-12-31) — EBITDA: 4015600000.00
CME income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 301100000.00
CME cash_flow (annual, 2022-12-31) — End Cash Position: 137974300000.00
CME cash_flow (annual, 2022-12-31) — Financing Cash Flow: -25381700000.00
CME cash_flow (annual, 2022-12-31) — Free Cash Flow: 2966300000.00
CME cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -4800000.00
CME cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CME cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
CME income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 2198400000.00
CME balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -133300000.00
CME income_statement (annual, 2022-12-31) — General And Administrative Expense: 137400000.00
CME balance_sheet (annual, 2022-12-31) — Goodwill: 10482500000.00
CME balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 30927500000.00
CME balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 491300000.00
CME balance_sheet (annual, 2022-12-31) — Gross PPE: 1600700000.00
CME income_statement (annual, 2022-12-31) — Gross Profit: 4266300000.00
CME cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 973400000.00
CME income_statement (annual, 2022-12-31) — Interest Expense: 162700000.00
CME income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 162700000.00
CME cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 133200000.00
CME balance_sheet (annual, 2022-12-31) — Invested Capital: 30317100000.00
CME cash_flow (annual, 2022-12-31) — Investing Cash Flow: -489800000.00
CME cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CME cash_flow (annual, 2022-12-31) — Issuance Of Debt: 741000000.00
CME balance_sheet (annual, 2022-12-31) — Leases: 224800000.00
CME balance_sheet (annual, 2022-12-31) — Long Term Debt: 3422400000.00
CME balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3422400000.00
CME cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 741000000.00
CME cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -756200000.00
CME balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1243700000.00
CME income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CME cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -402000000.00
CME balance_sheet (annual, 2022-12-31) — Net Debt: 718300000.00
CME income_statement (annual, 2022-12-31) — Net Income: 2691000000.00
CME income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 2657200000.00
CME income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 2691000000.00
CME income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 2691000000.00
CME income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 2691000000.00
CME cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 2691000000.00
CME income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 2691000000.00
CME income_statement (annual, 2022-12-31) — Net Interest Income: -162700000.00
CME cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 1900000.00
CME cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -15200000.00
CME cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -15200000.00
CME income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -162700000.00
CME cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -22733000000.00
CME balance_sheet (annual, 2022-12-31) — Net PPE: 455500000.00
CME cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -89700000.00
CME cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
CME cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CME balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -4048800000.00
CME balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 5361100000.00
CME balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 5361100000.00
CME income_statement (annual, 2022-12-31) — Normalized EBITDA: 1817200000.00
CME income_statement (annual, 2022-12-31) — Normalized Income: 996047016.02
CME cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3056000000.00
CME cash_flow (annual, 2022-12-31) — Operating Gains Losses: -4800000.00
CME income_statement (annual, 2022-12-31) — Operating Income: 3015900000.00
CME income_statement (annual, 2022-12-31) — Operating Revenue: 4753600000.00
CME balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 358932100.00
CME balance_sheet (annual, 2022-12-31) — Other Current Assets: 524900000.00
CME balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 137550100000.00
CME balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -133300000.00
CME income_statement (annual, 2022-12-31) — Other Gand A: 137400000.00
CME income_statement (annual, 2022-12-31) — Other Income Expense: 637100000.00
CME balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 20445000000.00
CME cash_flow (annual, 2022-12-31) — Other Non Cash Items: 41300000.00
CME balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 3714400000.00
CME balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 826000000.00
CME income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1862400000.00
CME income_statement (annual, 2022-12-31) — Other Operating Expenses: 750400000.00
CME balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 96000000.00
CME income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: -5100000.00
CME balance_sheet (annual, 2022-12-31) — Payables: 121400000.00